Patents by Inventor Helga HELGADOTTIR

Helga HELGADOTTIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230107742
    Abstract: This invention relates to novel synergy, where the antimicrobial effects of microbicidal lipids are augmented with minor amounts of ethanol, in particular to augment the microbicidal effects for preventing infection in the nasal, ocular, otal, pharynx, larynx, sinuses, oral cavity, vaginal or dermal surface of a mammal by virus, pathogenic bacteria or fungi.
    Type: Application
    Filed: December 8, 2022
    Publication date: April 6, 2023
    Inventors: Sveinbjorn GIZURARSON, Helga HELGADOTTIR, Thordis KRISTMUNDSDOTTIR, Halldor THORMAR, Sigurdur GUDMUNDSSON
  • Patent number: 11337949
    Abstract: A formulation to be used for administering a therapeutically effective amount of an antimicrobiologically active monoglyceride to a mammal including administering a pharmaceutical composition having a total volume of 1-5000 ?L to a surface of the mammal such as the nasal, ocular, otal, pharynx, larynx, sinuses, oral cavity, vaginal or dermal surface, the pharmaceutical composition including the therapeutically effective amount of the antimicrobiologically active monoglyceride dissolved or suspended in a volume of 1-5000 ?L of an methoxypolyethylene glycol referred to as mPEG and polyoxyethylene glycol (PEG)-fatty acid mono- or diglyceride so that upon administration of the pharmaceutical composition to the surface the formulation expresses thermostability within the range from below zero degrees C. to above 35-40° C. and thereby allows the antimicrobiologically active monoglyceride to exert its therapeutic effect.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: May 24, 2022
    Assignee: CAPRETTO EHF.
    Inventors: Sveinbjorn Gizurarson, Helga Helgadottir, Thordis Kristmundsdottir
  • Publication number: 20190209511
    Abstract: A formulation to be used for administering a therapeutically effective amount of an antimicrobiologically active monoglyceride to a mammal including administering a pharmaceutical composition having a total volume of 1-5000 ?L to a surface of the mammal such as the nasal, ocular, otal, pharynx, larynx, sinuses, oral cavity, vaginal or dermal surface, the pharmaceutical composition including the therapeutically effective amount of the antimicrobiologically active monoglyceride dissolved or suspended in a volume of 1-5000 ?L of an methoxypolyethylene glycol referred to as mPEG and polyoxyethylene glycol (PEG)-fatty acid mono- or diglyceride so that upon administration of the pharmaceutical composition to the surface the formulation expresses thermostability within the range from below zero degrees C. to above 35-40° C. and thereby allows the antimicrobiologically active monoglyceride to exert its therapeutic effect.
    Type: Application
    Filed: June 19, 2017
    Publication date: July 11, 2019
    Inventors: Sveinbjorn GIZURARSON, Helga HELGADOTTIR, Thordis KRISTMUNDSDOTTIR
  • Publication number: 20190209510
    Abstract: This invention relates to novel synergy, where the antimicrobial effects of microbicidal lipids are augmented with minor amounts of ethanol, in particular to augment the microbicidal effects for preventing infection in the nasal, ocular, otal, pharynx, larynx, sinuses, oral cavity, vaginal or dermal surface of a mammal by virus, pathogenic bacteria or fungi.
    Type: Application
    Filed: June 19, 2017
    Publication date: July 11, 2019
    Inventors: Sveinbjorn GIZURARSON, Helga HELGADOTTIR, Thordis KRISTMUNDSDOTTIR, Halldor THORMAR, Sigurdur GUDMUNDSSON